Findings indicate a sharp drop in immunity after Omicron infection, stressing the necessity for updated vaccines to enhance protection against reinfection.

Researchers have identified a novel genetic risk factor for SARS-CoV-2 infection, providing new insights into the virus's ability to invade human cells. SARS-CoV-2 is the virus that spreads COVID-19.

A study on bat genomes, involving Texas Tech University, discovered genetic adaptations that help bats resist viral ...

Infection with the SARS-CoV-2 Omicron variant confers weak, short-term protection against reinfection, compared with the much more robust and durable protection provided by earlier variants, which ...

A new study from researchers at Weill Cornell Medicine-Qatar (WCM-Q) reveals how the SARS-CoV-2 virus evolved from initially ...

The study revealed that a gene common in some bats can reduce the production of the SARS-CoV-2 virus by up to 90%, which could help lead to new medical approaches to combating viral diseases. "Bats ...

Scientists at the University of São Paulo analysed blood samples donated by six serodiscordant couples – the situation one ...

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is associated with more rapid progression of coronary ...

Now, with SARS-CoV-2 having infected more than 100 million people and counting, it’s clear that the virus can indeed lead to extensive damage outside of the lungs—damage that has contributed to a ...

The research paper is titled “Tofacitinib Mitigates the Increased SARS-CoV-2 Infection Susceptibility Caused by an IBD Risk Variant in the PTPN2 Gene.” The University of California ...